See how your reported results read as versioned evidence records — linked to experiments and limitations.Know what the science actually supports before you trust the answer.
Press Enter ↵ to review claims
Explore by Goal
"The biology of mind bridges the sciences – concerned with the natural world – and the humanities – concerned with the meaning of human experience."
- Eric Kandel
Quick Explanation
Copied
Yi Zeng — Scientific Strength Snapshot
Yi Zeng’s provided record shows strong experimental grounding across regenerative organoid biology, tumor microenvironment immuno-oncology, and RNA-methylation–linked cancer plasticity, plus in vivo neuroinflammation modulation—with recurring use of multi-modal evidence (functional assays, lineage/phenotyping, and (bio)informatics integration where relevant). Key scientific caveats are mostly the same: translation limits (species/model dependence), niche-mechanism incompleteness, and generalizability constraints of cell-line/xenograft systems.<
/div>
Evidence base used (from your dataset)
Pancreatic islet organoids from adult Procr+ progenitors (Cell, 2020)
LLM multi-agent survey (Oct 2024; non-biological, lower reproducibility since it’s a survey)
TAM IL6–STAT3–C/EBPβ positive feedback promoting EMT/metastasis (Journal of Experimental & Clinical Cancer Research, 2024)
YTHDC2 suppresses bladder cancer by blocking SOX2 translation (Cell Death & Disease, 2025)
SNCA knockdown via lentivirus after spinal cord injury shifts microglia/macrophages toward reparative states (Journal of Neuroinflammation, 2019)
Long Explanation
Author Review: Yi Zeng
Last update: 2026-04-12
This review is constrained to the papers provided in your dataset. I treat every biological/mechanistic claim as conditional on those paper results and highlight where the evidence supports inference vs where uncertainty remains.
These are not universal metrics of author impact; they are the numeric fields included in your dataset for each listed paper. I use them only to visualize internal consistency across topics.
Highest signals appear in the islet organoid work () and the bladder-cancer YTHDC2 mechanistic axis ().
Key quantitative anchors: Procr+ organoid lineage + function
The following bars use only the numeric values extracted in your dataset for the Procr+ organoid study.
The dataset reports Procr+ cells comprise ~1.0% ± 0.14% of the Lin− EpCAM+ islet epithelial population and that clones show a majority multi-lineage contribution (~70.3%) versus beta-only (~29.7%) in the lineage tracing summarized .
The extraction list states organoid engraftment restores glycemia comparably to a fresh-islet benchmark; I visualize only the extracted “similarity” figures.
The dataset extraction specifies: ~1,000 organoids (7th/15th passage) engrafted under the kidney capsule in STZ-diabetic mice produce glycemic rescue “similarly to ~300 fresh islets,” and that nephrectomy reverses the rescue .
This chart only uses numeric sample quantities present in your extraction list (patients, public dataset sizes, and animal n’s). When missing, I omit the point rather than guess.
Example scale anchors used: Procr+ study reports 7,160 primary pancreatic scRNA-seq cells ; TAM IL6 loop uses 14 treatment-naive LUAD patient samples for scRNA-seq ; YTHDC2–SOX2 reports 60 tumor tissues and 13 adjacent normals on tissue microarrays .
1) Strengths: multi-level biological evidence and mechanistic linking
Clear causal-leaning experimental designs appear in the islet organoid work (lineage tracing + clonal organoid formation + functional glucose-responsive secretion + in vivo transplantation rescue) .
Mechanistic depth using RNA-methylation assays + translation readouts + rescue is a standout pattern in the YTHDC2–SOX2 bladder cancer paper (e.g., binding/association claims via RIP/MeRIP/pull-down plus polysome profiling/luciferase/translation logic, and functional rescue by SOX2 overexpression) .
Immune-network hypotheses are tested with both patient-context profiling and functional perturbations in the TAM IL6 feedback paper (TAM correlation/progression signals via patient scRNA-seq + public datasets, then IL6/STAT3 pathway perturbations with EMT/metastasis phenotyping) .
Mouse/cell-line dependence limits direct translatability. The islet organoid paper acknowledges uncertainties about direct translation to human islets and notes that endothelial niche signaling isn’t fully defined .
In oncology work, functional causality can still be conditional because TAM biology differs between induced in vitro macrophage phenotypes and heterogeneous tumor TAM states, and because cell line/xenograft models may not fully capture patient microenvironments .
EMT–MET dynamics and context dependence in the YTHDC2 paper remain partially unresolved because it relies heavily on cell line and xenograft systems; the authors (per your extraction) call for single-cell analysis in primary samples to validate EMT/MET dynamics .
Neuroinflammation translation caveats: the SNCA knockdown study uses male Sprague-Dawley rats and notes that downstream signaling mechanisms remain undefined and off-target effects are possible (typical shRNA caveats) .
3) Bias/safety checks: conflict-of-interest and interpretation risk
Regenerative organoid technology has patent interests (per your extraction), which does not invalidate the biology, but increases the importance of independent replication .
Across mechanistic cancer papers, the dominant risks are not “data falsification” claims but typical biological inference risks: dependence on model context, incomplete pathway resolution, and the possibility that perturbations affect multiple nodes. The extracted limitation lists explicitly call out these interpretive boundaries for the TAM IL6 loop and YTHDC2–SOX2 axis .
4) Epistemic humility: what would most change the conclusion?
The strongest potential falsifiers across these topics would be: (i) inability of Procr+ progenitors to reproduce comparable lineage outcomes and functional rescue in human-relevant systems (e.g., human islet organoids/appropriate in vivo models), especially after endothelial niche components are systematically manipulated ; (ii) failure of IL6–STAT3–C/EBPβ circuitry to hold up under patient-primary TAM perturbation experiments and more realistic TAM-state modeling ; and (iii) discovery that YTHDC2 affects SOX2 translation via alternative indirect routes not robustly tied to m6A binding/translation readouts in diverse patient samples .
Topic coverage map (from provided record)
This map is descriptive only (no causal claims): the included scientific papers correspond to each topic node .
Bottom-line assessment (with confidence note)
Based on these provided papers alone, Yi Zeng’s scientific profile looks highly solid in executing biologically grounded studies that integrate state/lineage biology (organoids; EMT-like programs) with functional phenotyping (secretion, invasion, behavior) and, in the YTHDC2 work, mechanistic molecular assays tied to causality via rescue and translation readouts . Confidence is moderate rather than maximal because we only have a limited subset of the author’s full publication record and because translation/generalizability limitations are explicitly present in the extracted limitations sections .
It compiles extracted numeric highlights into a tidy table, then generates a multi-paper comparison dashboard (scores, sample scale, and Procr+ lineage fractions) for quick critical review.
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
The strong claim that all four endocrine lineages arise primarily from Procr+ cells in all contexts could be wrong if lineage tracing overestimates multipotency due to recombination efficiency or niche-dependent survival differences across endocrine subtypes.
The idea that YTHDC2’s tumor-suppressive effect is solely mediated through SOX2 translation might be incorrect if YTHDC2 also regulates parallel translation programs in pathways that dominate EMT/stemness phenotypes under certain microenvironmental states.
Explore by Goal
Quick Explanation
Long Explanation
Top Data Sources
Ask a Follow-Up
Key Insight
Keep Exploring
Analysis 
Hypothesis Graveyard
Potential Experiments
Discussion